Healthcare Spending Slowdown Sparked Accelerate's Ch. 11

By Alex Wittenberg · May 20, 2025, 4:36 PM EDT

Biotechnology company Accelerate faced regulatory challenges and weakened demand from hospitals for its diagnostics products before it filed for bankruptcy protection this month, and is now planning to sell its assets...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Bankruptcy Scorecard

Summary

Medical technology company Accelerate Diagnostics Inc. filed for Chapter 11 protection in Delaware bankruptcy court with $90.2 million of debt and a plan to sell the business to lender Indaba Capital Management for $36.9 million.

Case Number

1:25-bk-10837

Judge

Karen Owens

Venue

U.S. Bankruptcy Court for the District of Delaware

Capital Structure

Total Liabilities:

$90.2 million of debt

View Full Scorecard

Documents

Related Sections

Case Information

Case Title

Accelerate Diagnostics, Inc.

Case Number

1:25-bk-10837

Court

Delaware

Nature of Suit

Date Filed

May 08, 2025

Recent Articles By Alex